-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
February 10, 2010 - acute symptoms and exacerbations).1 Despite guidance surrounding asthma self-management
education and medication … found that adults with asthma and parents of children with
asthma have concerns about regular use of medication … Children >5 years with asthma of
any type and severity, symptomatic
or using asthma medication … nocturnal control, missed
school/work, daily activity tolerance
or restrictions)
Quick-relief medication … use,
long-term control medication use, and pulmonary function.
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - currently no widely implemented mechanism for the reverse flow of information on adverse
events and medication … also deficient in providing background data on number of
patients being administered a particular medication … A baseline information questionnaire is administered at the start of a medication to collect basic … information about the patient’s health status before medication. … Cohen MM, Kimmel NL, et al. (2005) “Medication Safety Program Reduces Adverse Drug
Events in a Community
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - currently no widely implemented mechanism for the reverse flow of information on adverse
events and medication … also deficient in providing background data on number of
patients being administered a particular medication … A baseline information questionnaire is administered at the start of a medication to collect basic … information about the patient’s health status before medication. … Cohen MM, Kimmel NL, et al. (2005) “Medication Safety Program Reduces Adverse Drug
Events in a Community
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
October 01, 2014 - • Medication adherence and persistence.
• School performance and attendance. … Long-term effects of ADHD medication on adult height:
results from NESARC. … Medication adherence was not significantly
different
We found no new studies of medication adherence … or another atypical antipsychotic medication
or the same atypical antipsychotic medication but at a … with standard/higher doses of
the same medication.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment-future_research.pdf
September 01, 2012 - advocated for the control of asthma given the range of
asthma severity and concerns about long-term medication … to guideline-based care, with the primary goals of improving
asthma control and reducing the use of medication … PEF and PFV);
cardiovascular outcomes (e.g., heart rate); quality of life (e.g., stress, anxiety); medication … There was moderate evidence that showed a reduction in asthma
symptoms and reliever medication use with … , but no more likely to improve asthma symptoms, medication use, quality of life, or
pulmonary function
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - disease in adults in the U.S.4 Costs related to diabetes
were approximately $245 billion in 2012.1
Medication … Including insulin, there are 10 medication classes with approval by the U.S. … combinations for adults with type 2 diabetes.10, 11 Data
on the newly-approved medication classes ( … We will not review these outcomes for
any medication classes or comparisons except those including SGLT … Priority Medication Comparisons Included for Each Key Question
Main Intervention Comparisons
Source
-
effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol
January 22, 2015 - Including insulin, there are 10 medication classes with approval by the U.S. … combinations for adults with type 2 diabetes. 10,11 Data on the newly-approved medication classes ( … We will not review these outcomes for any medication classes or comparisons except those including … Priority Medication Comparisons Included for Each Key Question
Type of Therapy
Main Intervention … We will then stratify studies by medication and repeat the pooled analyses and measures of heterogeneity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - Outcomes:
1) Relapse and remission rates.
2) Medication adherence and persistent use (and associated … We will compare medication-associated adverse events in FGAs and SGAs
(KQ3). … • Medication adherence and persistent use (associated dosing, time to
discontinuation of treatment … to have experienced the event and the total
number of patients in the medication groups in relevant … The dose of each
medication that is associated with an adverse event will be recorded to facilitate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surveillance-report-1-noninvasive-nonpharm-chronic-pain.xlsx
January 01, 2021 - use: 56% vs. 47%
RDQ (0–24)
Pain intensity, Brief Pain Inventory (0–10)
Opioid medication use
Other … 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13)
Opioid medication … Participants reported standard sleep variables, and if they had used (yes/no) any form of medication, … including sleep and opioid medication. … Primary outcomes were yes/no use of sleep medication or opioids. 6 months Mean (SE)
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma.xlsx
January 01, 2021 - use: 56% vs. 47%
RDQ (0–24)
Pain intensity, Brief Pain Inventory (0–10)
Opioid medication use
Other … 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13)
Opioid medication … Participants reported standard sleep variables, and if they had used (yes/no) any form of medication, … including sleep and opioid medication. … Primary outcomes were yes/no use of sleep medication or opioids. 6 months Mean (SE)
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
January 01, 2021 - use: 56% vs. 47%
RDQ (0–24)
Pain intensity, Brief Pain Inventory (0–10)
Opioid medication use
Other … 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13)
Opioid medication … Participants reported standard sleep variables, and if they had used (yes/no) any form of medication, … including sleep and opioid medication. … Primary outcomes were yes/no use of sleep medication or opioids. 6 months Mean (SE)
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - use: 56% vs. 47%
RDQ (0–24)
Pain intensity, Brief Pain Inventory (0–10)
Opioid medication use
Other … 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13)
Opioid medication … Participants reported standard sleep variables, and if they had used (yes/no) any form of medication, … including sleep and opioid medication. … Primary outcomes were yes/no use of sleep medication or opioids. 6 months Mean (SE)
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
October 25, 2022 - Those
of us who treat patients with epilepsy recognize that
medication toxicity and encephalopathy … Agree it is surprising there are no
data on this medication, but this is common for first line
medications … There is a distinction between
an adverse event on a medication vs. ill effects or side
effects that … Whelan, No
affiliation listed
Results Fifth: What is meant by "prior medication" (p. 43) as a
source … Authors did not state
specifically which baseline medication(s) had
caused these eye abnormalities;
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e5.xlsx
March 13, 2023 - intensity, current and past pain medications, comorbidities, comedications, and reasons for switching medication … gender, pain severity, stage of chronification, history/duration of pain, comorbidity, concomitant medication … , prior medication, and baseline
values A vs. … 0.14) vs. 0.07 (SD 0.27)
Strong opioid analgesics: 0.22 (SD 0.59) vs. 0.21 (SD 0.60)
Mean rescue pain medication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
January 01, 2022 - intensity, current and past pain medications, comorbidities, comedications, and reasons for switching medication … gender, pain severity, stage of chronification, history/duration of pain, comorbidity, concomitant medication … , prior medication, and baseline
values A vs. … 0.14) vs. 0.07 (SD 0.27)
Strong opioid analgesics: 0.22 (SD 0.59) vs. 0.21 (SD 0.60)
Mean rescue pain medication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - intensity, current and past pain medications, comorbidities, comedications, and reasons for switching medication … gender, pain severity, stage of chronification, history/duration of pain, comorbidity, concomitant medication … , prior medication, and baseline
values A vs. … 0.14) vs. 0.07 (SD 0.27)
Strong opioid analgesics: 0.22 (SD 0.59) vs. 0.21 (SD 0.60)
Mean rescue pain medication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - use, and combined asthma plus rhinoconjunctivitis
medication use. … The strength of evidence is low that subcutaneous
immunotherapy reduces combined symptom-medication … symptom-medication scores. … plus symptom scores, conjunctivitis symptoms,
and medication use, and improves quality of life. … plus symptom scores, conjunctivitis symptoms, medication
use, and improves quality of life.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
January 01, 2015 - reduce diabetes complications.3-5
When beginning medical treatment,
patients usually begin with a medication … Priority medication comparisons included for each Key Question
Intervention
Main Intervention Class … Interventions • We included studies that evaluated a diabetes medication of interest or drug combination … Weight
Monotherapy and combination medication comparisons
generally showed significant between-group … Medication use leading
to emergency department visits for adverse drug events in older
adults.
-
effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
April 24, 2015 - . 6 Comparative effectiveness for combined AB/5-ARI therapy is superior to monotherapy with either medication … variety of medications available to treat LUTS/BPH, tailoring treatment with single medications or medication … Common medications used to treat LUTS associated with BPH
Drug class
Mechanism of action
Medication … Comparators
Placebo or other FDA approved medication ( Table 1 )
Outcomes
Primary Outcomes … Adverse effects of intervention(s)
Common and serious medication side effects
Timing
Short term
-
effectivehealthcare.ahrq.gov/products/copd-management/research
December 04, 2009 - Two approaches were used, the first where treatment assignment was based on medication use at baseline